HighGravityDataSigned in · PRO
Guidance history, every release
Raised · a change from the previous releaseSame · restated unchanged— · not stated in that releaseEvery value links to its sentence in the filing
| Metric | Oct 16, 2024 FY24 Q3 | Jan 22, 2025 FY24 Q4 | Apr 16, 2025 FY25 Q1 | Jul 17, 2025 FY25 Q2 | Oct 15, 2025 FY25 Q3 | Jan 22, 2026 FY25 Q4 | Apr 16, 2026 FY26 Q1 | Jul 16, 2026 FY26 Q2 |
|---|---|---|---|---|---|---|---|---|
| For FY2028 | ||||||||
| New cardiovascular device manufacturing facility in Georgia | — | — | — | New“to be completed by 2028” | — | — | — | — |
| For FY2026 | ||||||||
| Comparable sales growth | — | — | — | — | — | — | New“6.5% to 7.5%” | Reiterated“6.5% to 7.5%” |
| Adjusted diluted earnings per share | — | — | — | — | — | — | — | New“$1.38 to $1.46” |
| Adjusted diluted earnings per share | — | — | — | — | — | — | — | New“$5.45 to $5.60” |
| Adjusted diluted earnings per share | — | — | — | — | — | — | — | New“$1.38 to $1.46” |
| Adjusted diluted earnings per share | — | — | — | — | — | New“$5.55 to $5.80” | Lowered“$5.38 to $5.58” | — |
| Adjusted diluted earnings per share | — | — | — | — | — | — | New“$1.25 to $1.31” | — |
| Adjusted diluted earnings per share | — | — | — | — | — | — | New“$1.25 to $1.31” | — |
| Adjusted diluted earnings per share | — | — | — | — | — | New“$1.12 to $1.18” | — | — |
| Adjusted diluted earnings per share | — | — | — | — | — | New“$1.12 to $1.18” | — | — |
| Adjusted diluted EPS | — | — | — | — | — | — | — | New“$5.45 to $5.60” |
| Organic sales growth | — | — | — | — | — | New“6.5% to 7.5%” | — | — |
| Quarterly dividend | — | — | — | — | — | — | — | New“$0.63 per share” |
| Quarterly dividend | — | — | — | — | — | — | New“$0.63 per share” | — |
| For FY2025 | ||||||||
| Adjusted diluted earnings per share | — | — | — | New“$5.10 to $5.20” | — | — | — | — |
| Adjusted diluted earnings per share | — | — | — | New“$1.28 to $1.32” | — | — | — | — |
| Adjusted diluted earnings per share | — | — | New“$5.05 to $5.25” | — | — | — | — | — |
| Adjusted diluted earnings per share | — | — | New“$1.23 to $1.27” | — | — | — | — | — |
| Adjusted diluted earnings per share | — | New“$5.05 to $5.25” | — | — | — | — | — | — |
| Adjusted diluted EPS | — | — | — | — | New“$5.12 to $5.18” | — | — | — |
| Adjusted diluted EPS | — | New“$5.05 to $5.25” | — | — | — | — | — | — |
| Adjusted diluted EPS | — | New“$1.05 to $1.09” | — | — | — | — | — | — |
| Adjusted operating margin | — | — | — | New“approximately 23.5%” | — | — | — | — |
| Adjusted operating margin | — | New“23.5% to 24.0% of sales” | Reiterated“23.5% to 24.0% of sales” | — | — | — | — | — |
| Organic sales growth | — | New“7.5% to 8.5%” | Reiterated“7.5% to 8.5%” | — | Changed“7.5% to 8.0%, excluding COVID-19 testing-related sales, or 6.0% to 7.0%, when including COVID-19 testing-related sales” | — | — | — |
| Organic sales growth, excluding COVID-19 testing-related sales | — | — | — | New“7.5% to 8.0%” | Reiterated“7.5% to 8.0%” | — | — | — |
| Organic sales growth, including COVID-19 testing-related sales | — | — | — | New“6.0% to 7.0%” | Reiterated“6.0% to 7.0%” | — | — | — |
| Quarterly dividend | — | — | — | — | New“$0.59 per share” | — | — | — |
| For FY2024 | ||||||||
| Adjusted diluted EPS | New“$1.31 to $1.37” | — | — | — | — | — | — | — |
| Adjusted diluted EPS | New“$4.64 to $4.70” | — | — | — | — | — | — | — |
| Diluted EPS (GAAP) | New“$0.96 to $1.02” | — | — | — | — | — | — | — |
| Diluted EPS on a GAAP basis | New“$3.34 to $3.40” | — | — | — | — | — | — | — |
| Diluted EPS under GAAP | New“$0.96 to $1.02” | — | — | — | — | — | — | — |
| Organic sales growth, excluding COVID-19 testing-related sales | New“9.5% to 10.0%” | — | — | — | — | — | — | — |
| Specified items per share forecast | New“$1.30 per share” | — | — | — | — | — | — | — |
| Specified items per share forecast | New“$0.35 per share” | — | — | — | — | — | — | — |
| No period stated | ||||||||
| New share repurchase program authorization | New“up to $7 billion” | — | — | — | — | — | — | — |
| Quarterly dividend | New“$0.55 per share” | Raised“$0.59 per share” | Reiterated“$0.59 per share” | — | — | Raised“$0.63 per share” | — | — |
Values in quotation marks are the company’s words. Change labels compare each statement with the same metric and target year in the previous release. HighGravityData does not judge whether guidance was met.